Targeting telomeres to overcome therapy resistance in advanced melanoma

(The Wistar Institute) A study conducted at The Wistar Institute in collaboration with The University of Texas Southwestern Medical Center has demonstrated the efficacy of targeting aberrantly active telomerase to treat therapy-resistant melanoma.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news